East Asia Joins Hands To Tackle Common Health Issues
This article was originally published in PharmAsia News
Health ministers from South Korea, Japan and China met in Kyoto, Japan on Nov. 29 to step up joint efforts to deal with health and medical issues in the three countries such as new infectious diseases, aging societies and non-communicable diseases. Ways to share information and cooperate in technology, including possibly forming a tripartite consultative body, were among the issues under discussion.
You may also be interested in...
Through a licensing-out deal with ORIC for its EGFR/HER2 exon-20 inhibitor, South Korea's Voronoi hopes to gain from its new partner's commercialization experience in NSCLC. The alliance hopes to build a potentially best-in-class presence in a competitive landscape.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Korean venture Helixmith faces another setback following a missed Phase III endpoint for its plasmid DNA neuropathy candidate, with its shares plunging after it warned of a possible delay in a planned rights offering, amid concerns from minority shareholders over other investment losses.